SUPPLEMENT

Q1 2024 — Financial statement information

Q1 2024PDF · 16 pages312 KB
Three months ended
March 31,
2024 2023
Net sales $ 8,003 $ 8,031
Operating expenses
Cost of sales 4,329 4,613
Selling, general and administrative expenses 1,736 1,705
Research, development and related expenses 437 472
Total operating expenses 6,502 6,790
Operating income (loss) 1,501 1,241
Other expense (income), net 264 52
Income (loss) before income taxes 1,237 1,189
Provision (benefit) for income taxes 305 210
Income (loss) of consolidated group 932 979
Income (loss) from unconsolidated subsidiaries, net of taxes 1 2
Net income (loss) including noncontrolling interest 933 981
Less: Net income (loss) attributable to noncontrolling interest 5 5
Net income (loss) attributable to 3M $ 928 $ 976
Weighted average 3M common shares outstanding – basic 555.0 552.7
Earnings (loss) per share attributable to 3M common shareholders — basic $ 1.67 $ 1.77
Weighted average 3M common shares outstanding – diluted 555.9 553.2
Earnings (loss) per share attributable to 3M common shareholders — diluted $ 1.67 $ 1.76
3M Company and Subsidiaries
CONSOLIDATED STATEMENT OF INCOME (LOSS)
(Millions, except per-share amounts)
(Unaudited)
1

-- 1 of 16 --

March 31,
2024 December 31,
2023
ASSETS
Current assets
Cash and cash equivalents $ 10,911 $ 5,933
Marketable securities – current 60 53
Accounts receivable – net 4,750 4,750
Inventories 4,897 4,822
Prepaids 655 485
Other current assets 340 336
Total current assets 21,613 16,379
Property, plant and equipment – net 9,072 9,159
Operating lease right of use assets 744 759
Goodwill and intangible assets – net 16,914 17,153
Other assets 6,900 7,130
Total assets $ 55,243 $ 50,580
LIABILITIES AND EQUITY
Current liabilities
Short-term borrowings and current portion of long-term debt $ 820 $ 2,947
Accounts payable 3,372 3,245
Accrued payroll 607 904
Accrued income taxes 383 365
Operating lease liabilities – current 227 225
Other current liabilities 7,747 7,611
Total current liabilities 13,156 15,297
Long-term debt 20,593 13,088
Other liabilities 16,561 17,327
Total liabilities 50,310 45,712
Total equity 4,933 4,868
Shares outstanding
March 31, 2024: 553,361,257
December 31, 2023: 552,581,136
Total liabilities and equity $ 55,243 $ 50,580
3M Company and Subsidiaries
CONDENSED CONSOLIDATED BALANCE SHEET
(Dollars in millions)
(Unaudited)
2

-- 2 of 16 --

Three months ended March 31,
2024 2023
NET CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES $ 767 $ 1,275
Cash flows from investing activities:
Purchases of property, plant and equipment (375) (475)
Purchases and proceeds from sale or maturities of marketable securities and
investments – net (11) 86
Other investing activities (7) 3
NET CASH PROVIDED BY (USED IN) INVESTING ACTIVITIES (393) (386)
Cash flows from financing activities:
Change in debt – net 5,509 (43)
Purchases of treasury stock (21) (29)
Proceeds from issuances of treasury stock pursuant to stock option and
benefit plans 18 187
Dividends paid to shareholders (835) (827)
Other financing activities (50) (4)
NET CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES 4,621 (716)
Effect of exchange rate changes on cash and cash equivalents (17) (4)
Net increase (decrease) in cash and cash equivalents 4,978 169
Cash and cash equivalents at beginning of year 5,933 3,655
Cash and cash equivalents at end of period $ 10,911 $ 3,824
3M Company and Subsidiaries
CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS
(Dollars in millions)
(Unaudited)
3

-- 3 of 16 --

Three months ended March 31, 2024
Sales Change Analysis By Geographic Area Americas Asia Pacific Europe, Middle
East and Africa Worldwide
Organic sales (1.5) % 0.9 % 3.3 % — %
Acquisitions 0.6 0.1 0.1 0.4
Divestitures — (0.1) (0.3) (0.1)
Translation 0.4 (4.3) 1.7 (0.6)
Total sales change (0.5) % (3.4) % 4.8 % (0.3) %
Three months ended March 31, 2024
Worldwide Sales Change By Business Segment Organic sales Acquisitions Divestitures Translation Total sales
change
Safety and Industrial (1.4) % — % — % (0.3) % (1.7) %
Transportation and Electronics 2.7 1.4 — (1.5) 2.6
Health Care 1.0 — (0.3) (0.4) 0.3
Consumer (3.9) — — (0.4) (4.3)
Total Company — 0.4 (0.1) (0.6) (0.3)
4Total sales change is calculated based on reported sales results. The components of sales change include organic local- currency sales,
acquisitions, divestitures, and translation. Organic local-currency sales include both organic volume impacts (which excludes acquisition and
divestiture impacts) and selling price changes. Acquisition and divestiture impacts are measured separately for the first 12 months post-
transaction and, beginning April 2024, include the impact of commercial agreements associated with the separation of Solventum.
3M Company and Subsidiaries
SALES CHANGE ANALYSIS4
(Unaudited)
4

-- 4 of 16 --

3M discloses business segment operating income (loss) as its measure of segment profit/loss, reconciled to both total 3M
operating income (loss) and income (loss) before taxes. Business segment operating income (loss) excludes certain expenses
and income that are not allocated to business segments (as described below in “Corporate and Unallocated”).
Effective in the first quarter of 2024, 3M made certain changes within its business segments in its continuing effort to improve
the alignment of businesses around markets and customers. The changes included the items described below. While they
impacted the composition of certain divisions within 3M's business segments, they did not change the overall composition of
segments or the measure of segment operating performance used by 3M’s chief operating decision maker (CODM). The
financial information presented herein reflects the impact of these changes for all periods presented.
Creation of Industrial Specialties division (within Safety and Industrial business segment) and Commercial Branding and
Transportation division (within Transportation and Electronics business segment)
3M created the Industrial Specialties division within Safety and Industrial business segment, which consists of the former
Closure and Masking Systems division along with certain products formerly within Industrial Adhesive and Tapes division
and the Personal Safety division. Further, 3M created the Commercial Branding and Transportation division within the
Transportation and Electronics business segment, which consists of the former Commercial Solutions division and the
Transportation Safety division.
Re-alignment from three to four divisions within Consumer business segment
The Consumer business segment re-aligned from three divisions to the following four divisions: Consumer Safety and
Well-Being, Home and Auto Care, Home Improvement, and Packaging and Expression.
Division name changes within the Health Care business segment
The names of three of the Heath Care segment's divisions were changed. The Medical Solutions, Oral Care, and Separation
and Purification Sciences divisions were renamed to Medical Surgical (MedSurg), Dental Solutions, and Purification and
Filtration, respectively.
BUSINESS SEGMENT INFORMATION Three months ended
March 31,	NET SALES
(Millions) 2024 2023
Safety and Industrial $ 2,732 $ 2,779
Transportation and Electronics 2,104 2,050
Health Care 2,017 2,010
Consumer 1,140 1,192
Corporate and Unallocated 10 —
Total Company $ 8,003 $ 8,031
3M Company and Subsidiaries
BUSINESS SEGMENTS
(Unaudited)
5

-- 5 of 16 --

BUSINESS SEGMENT INFORMATION Three months ended
March 31,	OPERATING INCOME (LOSS)
(Millions) 2024 2023
Safety and Industrial $ 657 $ 601
Transportation and Electronics 481 294
Health Care 354 360
Consumer 216 179
Total business segment operating income (loss) 1,708 1,434
Corporate and Unallocated
Corporate special items:
Net costs for significant litigation (63) (82)
Divestiture costs (121) (102)
Total corporate special items (184) (184)
Other corporate (expense) income - net (23) (9)
Total Corporate and Unallocated (207) (193)
Total Company operating income (loss) 1,501 1,241
Other expense/(income), net 264 52
Income (loss) before income taxes $ 1,237 $ 1,189
Corporate and Unallocated
Corporate and Unallocated operating income (loss) includes “corporate special items” and “other corporate expense-net”.
Corporate special items include net costs for significant litigation impacting operating income (loss) associated with PFAS-
related other environmental and Combat Arms Earplugs matters. In addition, during the voluntary chapter 11 bankruptcy period
(which began in July 2022 and ended in June 2023) costs associated with the Aearo portion of respirator mask/asbestos matters
were also included in corporate special items. Prior to the bankruptcy, costs associated with Combat Arms Earplugs matters
were not included in the Corporate net costs for significant litigation special item, instead being reflected in the Safety and
Industrial business segment. Corporate special items also include divestiture costs and divestiture-related restructuring costs
impacting operating income. Divestiture costs include costs related to separating and divesting substantially an entire business
segment of 3M following public announcement of its intended divestiture. Other corporate expense-net includes certain
enterprise and governance activities resulting in unallocated corporate costs and other activity and net costs that 3M may choose
not to allocate directly to its business segments. Because Corporate and Unallocated includes a variety of miscellaneous items,
it is subject to fluctuation on a quarterly and annual basis.
3M Company and Subsidiaries
BUSINESS SEGMENTS - (CONTINUED)
(Unaudited)
6

-- 6 of 16 --

In addition to reporting financial results in accordance with U.S. GAAP, 3M also provides certain non-GAAP measures. These
measures are not in accordance with, nor are they a substitute for GAAP measures, and may not be comparable to similarly
titled measures used by other companies.
Certain measures adjust for the impacts of special items. Special items for the periods presented include the items described in
the section entitled “Description of special items”. Because 3M provides certain information with respect to business segments,
it is noteworthy that special items impacting operating income (loss) are reflected in Corporate and Unallocated, except as
described with respect to net costs for significant litigation and manufactured PFAS products items in the “Description of
special items” section. The reconciliations below, therefore, also include impacted segments as applicable.
This document contains measures for which 3M provides the reported GAAP measure and a non-GAAP measure adjusted for
special items. The document also contains additional measures which are not defined under U.S. GAAP. These measures and
reasons 3M believes they are useful to investors (and, as applicable, used by 3M) include:
GAAP amounts for which a measure adjusted for
special items is also provided: Reasons 3M believes the measure is useful
• Net sales (and sales change)
Considered, in addition to segment operating performance, in
evaluating and managing operations; useful in understanding
underlying business performance, provides additional transparency to
special items
• Operating income (loss), segment operating
income (loss) and operating income (loss) margin
• Other expense (income), net
• Income (loss) before taxes
• Provision for income taxes and effective tax rate
• Net income (loss)
• Earnings (loss) per share
Additional non-GAAP measures:
• Adjusted net cash provided by (used in)
operating activities; adjusted purchases of
property, plant and equipment (also referred to as
adjusted capital expenditures); adjusted free cash
flow and adjusted free cash flow conversion
Used as indicators of strength and ability to generate cash and as
indicator of capital deployment; meaningful as measures of
performance
• Adjusted EBITDA and adjusted EBITDA margin Considered in evaluating and managing operations; meaningful in
analyses of ongoing underlying operating trends
• Net debt Meaningful as indicator of liquidity and measure of capital structure
strategy
The following provides additional information and applicable GAAP amounts reconciled to non-GAAP measures.
3M Company and Subsidiaries
SUPPLEMENTAL FINANCIAL INFORMATION
NON-GAAP MEASURES
(Unaudited)
7

-- 7 of 16 --

Certain amounts adjusted for special items (non-GAAP measures):
Three months ended March 31, 2023
(Dollars in millions, except per share amounts) Net sales
Operating
income
(loss)
Operating
income
(loss)
margin
Other
expense
(income),
net
Income
(loss)
before
taxes
Provision
(benefit)
for income
taxes Effective
tax rate
Net income
(loss)
attributable
to 3M
Earnings per diluted
share
Safety and Industrial
GAAP amounts $ 601 21.6 %
Adjustments for special items:
Net costs for significant litigation (39)
Total special items (39)
Adjusted amounts (non-GAAP measures)5 $ 562 20.2 %
Transportation and Electronics
GAAP amounts $ 2,050 $ 294 14.4 %
Adjustments for special items:
Manufactured PFAS products (345) (10)
Total special items (345) (10)
Adjusted amounts (non-GAAP measures)5 $ 1,705 $ 284 16.7 %
Total Company
GAAP amounts $ 8,031 $ 1,241 15.4 % $ 52 $ 1,189 $ 210 17.7 % $ 976 $ 1.76
Adjustments for special items:
Net costs for significant litigation — 43 — 43 7 36 0.07
Manufactured PFAS products (345) (10) — (10) (3) (7) (0.01)
Divestiture costs — 102 — 102 20 82 0.15
Total special items (345) 135 — 135 24 111 0.21
Adjusted amounts (non-GAAP measures)5 $ 7,686 $ 1,376 17.9 % $ 52 $ 1,324 $ 234 17.7 % $ 1,087 $ 1.97
Three months ended March 31, 2024
(Dollars in millions, except per share amounts) Net sales
Sales
change
Operating
income
(loss)
Operating
income
(loss)
margin
Other
expense
(income),
net
Income
(loss)
before
taxes
Provision
(benefit)
for income
taxes Effective
tax rate
Net income
(loss)
attributable
to 3M
Earnings
(loss) per
diluted
share
Earnings
(loss) per
diluted
share
percent
change
Safety and Industrial
GAAP amounts $ 657 24.1 %
Adjustments for special items:
Net costs for significant litigation 7
Total special items 7
Adjusted amounts (non-GAAP measures)5 $ 664 24.3 %
Transportation and Electronics
GAAP amounts $ 2,104 2.6 % $ 481 22.9 %
Adjustments for special items:
Manufactured PFAS products (281) (2)
Total special items (281) (2)
Adjusted amounts (non-GAAP measures)5 $ 1,823 6.9 % $ 479 26.3 %
Total Company
GAAP amounts $ 8,003 (0.3) % $ 1,501 18.8 % $ 264 $ 1,237 $ 305 24.7 % $ 928 $ 1.67 (5) %
Adjustments for special items:
Net costs for significant litigation — 70 (204) 274 31 243 0.44
Manufactured PFAS products (281) (2) — (2) (1) (1) —
Divestiture costs — 121 (44) 165 8 157 0.28
Total special items (281) 189 (248) 437 38 399 0.72
Adjusted amounts (non-GAAP measures)5 $ 7,722 0.5 % $ 1,690 21.9 % $ 16 $ 1,674 $ 343 20.5 % $ 1,327 $ 2.39 21 %
3M Company and Subsidiaries
SUPPLEMENTAL FINANCIAL INFORMATION
NON-GAAP MEASURES – (CONTINUED)
(Unaudited)
8

-- 8 of 16 --

Year ended December 31, 2023
(Dollars in millions, except per share amounts) Net sales Sales change
Income (loss)
before taxes
Provision
(benefit) for
income taxes Effective tax
rate
Net income (loss)
attributable to 3M
Earnings (loss)
per diluted
share
Total Company
GAAP amounts $ 32,681 (4.5) % $ (9,688) $ (2,691) 27.8 % $ (6,995) $ (12.63)
Adjustments for special items:
Net costs for significant litigation6 — 15,245 3,615 11,630 21.00
Manufactured PFAS products (1,289) 205 50 155 0.28
Gain on business divestitures — (36) (11) (25) (0.05)
Russia exit charges (benefits) — (18) 3 (21) (0.04)
Divestiture costs — 496 118 378 0.68
Total special items (1,289) 15,892 3,775 12,117 21.87
Adjusted amounts (non-GAAP measures)5 $ 31,392 (4.5) % $ 6,204 $ 1,084 17.5 % $ 5,122 $ 9.24
5These items represent amounts adjusted for special items. See lead-in to non-GAAP measures discussion.
6For the per share amount, this includes adjusting-out the impact of this item causing weighted average shares outstanding to be the same for
both basic and diluted loss per share in periods of resulting net losses.
Year ended December 31, 2023
Sales Change4
Organic
sales Acquisitions Divestitures Translation Total sales
change
Total Company (3.2) % 0.2 % (0.9) % (0.6) % (4.5) %
Remove manufactured PFAS products special item impact — — (0.1) 0.1 —
Adjusted total Company (non-GAAP measures)5 (3.2) % 0.2 % (1.0) % (0.5) % (4.5) %
Three months ended March 31, 2024
Sales Change4
Organic
sales Acquisitions Divestitures Translation Total sales
change
Total Company — % 0.4 % (0.1) % (0.6) % (0.3) %
Remove manufactured PFAS products special item impact 0.8 — — — 0.8
Adjusted total Company (non-GAAP measures)5 0.8 % 0.4 % (0.1) % (0.6) % 0.5 %
Transportation and Electronics 2.7 % 1.4 % — % (1.5) % 2.6 %
Remove manufactured PFAS products special item impact 4.0 0.3 — — 4.3
Adjusted Transportation and Electronics (non-GAAP measures)5 6.7 % 1.7 % — % (1.5) % 6.9 %
By Geographic Area
Americas (1.5) % 0.6 % — % 0.4 % (0.5) %
Remove manufactured PFAS products special item impact 0.6 — — — 0.6
Adjusted Americas (non-GAAP measures)5 (0.9) % 0.6 % — % 0.4 % 0.1 %
Asia Pacific 0.9 % 0.1 % (0.1) % (4.3) % (3.4) %
Remove manufactured PFAS products special item impact 1.7 — — — 1.7
Adjusted Asia Pacific (non-GAAP measures)5 2.6 % 0.1 % (0.1) % (4.3) % (1.7) %
Europe, Middle East & Africa 3.3 % 0.1 % (0.3) % 1.7 % 4.8 %
Remove manufactured PFAS products special item impact — — — — —
Adjusted Europe, Middle East & Africa (non-GAAP measures)5 3.3 % 0.1 % (0.3) % 1.7 % 4.8 %
3M Company and Subsidiaries
SUPPLEMENTAL FINANCIAL INFORMATION
NON-GAAP MEASURES – (CONTINUED)
(Unaudited)
9

-- 9 of 16 --

Adjusted net cash provided by (used in) operating activities; adjusted purchases of property, plant and equipment (also
referred to as adjusted capital expenditures); adjusted free cash flow and adjusted free cash flow conversion (non-
GAAP measures):
Three months ended
March 31,
Major GAAP Cash Flow Categories (dollars in millions) 2024 2023
Net cash provided by (used in) operating activities $ 767 $ 1,275
Net cash provided by (used in) investing activities (393) (386)
Net cash provided by (used in) financing activities 4,621 (716)
Three months ended
March 31,
Adjusted Free Cash Flow (non-GAAP measure) (dollars in millions) 2024 2023
Net cash provided by (used in) operating activities $ 767 $ 1,275
Adjustments for special items:
Net costs for significant litigation after-tax payment impacts 351 58
Divestiture costs after-tax payment impacts 139 43
Divestiture-related restructuring after-tax payment impacts 1 2
Manufactured PFAS products impact after-tax payment impacts (70) 13
Total adjustments for special items 421 116
Adjusted net cash provided by (used in) operating activities (non-GAAP
measure)7 $ 1,188 $ 1,391
Purchases of property, plant and equipment (PPE) (375) (475)
Manufactured PFAS products impact - removing related purchases of PPE
20 30
Adjusted purchases of PPE (non-GAAP measure)7 $ (355) $ (445)
Adjusted free cash flow (non-GAAP measure)7 $ 833 $ 946
Adjusted net income (loss) attributable to 3M (non-GAAP measure)5 $ 1,327 $ 1,087
Adjusted free cash flow conversion (non-GAAP measure)7 63 % 87 %
73M defines adjusted net cash provided by (used in) operating activities as net cash provided by operating activities, adjusted for special
items. 3M defines adjusted purchases of property, plant and equipment (also referred to as adjusted capital expenditures) as purchases of
property, plant and equipment (PPE) adjusted for the estimated impact of such purchases associated with manufactured PFAS products
activity. 3M defines adjusted free cash flow as adjusted net cash provided by (used in) operating activities less adjusted purchases of PPE.
Cash payments/receipts associated with special items in the determination of adjusted net cash provided by (used in) operating activities are
reflected net of applicable tax. The cash tax impact for the portion of payments of costs for significant litigation under the 2023 settlement
agreements relative to Combat Arms Earplugs and relative to public water systems regarding PFAS is based on the timing/amount of the
actual cash tax deduction (which differs from the timing of the pre-tax settlement payments). The impacts of certain tax-related divestiture
costs are based on applicable tax rates and the timing of tax payments relative to underlying separation transactions. For other special items,
the cash tax impact is estimated using the U.S. statutory corporate tax rate during the period of payment/receipt. 3M defines adjusted free cash
flow conversion as adjusted free cash flow divided by net income (loss) attributable to 3M, adjusted for special items.
3M Company and Subsidiaries
SUPPLEMENTAL FINANCIAL INFORMATION
NON-GAAP MEASURES – (CONTINUED)
(Unaudited)
10

-- 10 of 16 --

Adjusted EBITDA and adjusted EBITDA margin (non-GAAP measures):
Adjusted EBITDA (non-GAAP measure)8 Adjusted EBITDA margin (non-GAAP measure)8
Three months ended
March 31, Three months ended
March 31,
(Dollars in millions) 2024 2023 2024 2023
Safety and Industrial $ 799 $ 696 29.3 % 25.0 %
Transportation and Electronics 562 361 30.8 % 21.2 %
Health Care 504 510 25.0 % 25.3 %
Consumer 254 217 22.3 % 18.2 %
Corporate and Unallocated (23) 29
Total Company $ 2,096 $ 1,813 27.1 % 23.6 %
Three months ended
March 31,
Adjusted EBITDA (non-GAAP measure) (dollars in millions) 2024 2023
Adjusted net sales (non-GAAP measure)5 $ 7,722 $ 7,686
Net income (loss) attributable to 3M 928 976
Add/(subtract):
Net income/(loss) attributable to noncontrolling interest 5 5
(Income)/loss from unconsolidated subsidiaries, net of taxes (1) (2)
Provision for income taxes 305 210
Other expense/(income):
Interest (Income)/expense 275 83
Pension & OPEB non-service cost (benefit) (11) (31)
Depreciation and amortization (DA) expense 430 466
Adjustments for special items:
Net costs for significant litigation 70 43
Manufactured PFAS products impact:
Remove manufactured PFAS products operating (income) loss (2) (10)
Subtract PFAS-related amount included in DA above (24) (29)
Divestiture costs 121 102
Total special items 165 106
Adjusted EBITDA (non-GAAP measure)8 $ 2,096 $ 1,813
Adjusted EBITDA margin (non-GAAP measure)8 27.1 % 23.6 %
83M defines adjusted EBITDA as net income (loss) attributable to 3M, adjusted for net income/(loss) attributable to noncontrolling interest,
(income)/loss from unconsolidated subsidiaries, provision for income taxes, other expense/(income), depreciation and amortization expense,
and special items. For business segments, 3M defines adjusted EBITDA as business segment operating income (loss) (3M’s measure of
segment operating performance) adjusted for special items that is then further adjusted for depreciation and amortization (DA) expense, net of
the PFAS-related amount included in DA. The Company defines adjusted EBITDA margin as adjusted EBITDA divided by net sales,
adjusted for special items.
3M Company and Subsidiaries
SUPPLEMENTAL FINANCIAL INFORMATION
NON-GAAP MEASURES – (CONTINUED)
(Unaudited)
11

-- 11 of 16 --

Adjusted EBITDA (non-GAAP measure)
Three months ended March 31, 2024 (dollars in
millions) Safety and
Industrial
Transportation
and
Electronics Health Care Consumer
Corporate
and
Unallocated Total
Company
Adjusted net sales (non-GAAP measure)5 $ 2,732 $ 1,823 $ 2,017 $ 1,140 $ 10 $ 7,722
Business segment operating income (loss)
(measure of segment operating
performance), adjusted for special
items (non-GAAP measure)5 $ 664 $ 479 $ 354 $ 216 $ (23) $ 1,690
Add/(subtract):
Add depreciation and amortization (DA)
expense 135 107 150 38 — 430
Subtract PFAS-related amount included
in DA above — (24) — — — (24)
Adjusted EBITDA (non-GAAP
measure)8 $ 799 $ 562 $ 504 $ 254 $ (23) $ 2,096
Adjusted EBITDA margin (non-GAAP
measure)8 29.3 % 30.8 % 25.0 % 22.3 % 27.1 %
Adjusted EBITDA (non-GAAP measure)
Three months ended March 31, 2023 (dollars in
millions) Safety and
Industrial
Transportation
and
Electronics Health Care Consumer
Corporate
and
Unallocated Total
Company
Adjusted net sales (non-GAAP measure)5 $ 2,779 $ 1,705 $ 2,010 $ 1,192 $ — $ 7,686
Business segment operating income (loss)
(measure of segment operating
performance), adjusted for special
items (non-GAAP measure)5 $ 562 $ 284 $ 360 $ 179 $ (9) $ 1,376
Add/(subtract):
Add depreciation and amortization (DA)
expense 134 106 150 38 38 466
Subtract PFAS-related amount included
in DA above — (29) — — — (29)
Adjusted EBITDA (non-GAAP
measure)8 $ 696 $ 361 $ 510 $ 217 $ 29 $ 1,813
Adjusted EBITDA margin (non-GAAP
measure)8 25.0 % 21.2 % 25.3 % 18.2 % 23.6 %
Net debt (non-GAAP measure):
Net Debt (non-GAAP measure) March 31, 2024 December 31, 2023
Total debt $ 21,413 $ 16,035
Less: Cash, cash equivalents and marketable securities 10,991 6,006
Net debt (non-GAAP measure)9 $ 10,422 $ 10,029
9The Company defines net debt as total debt less the total of cash, cash equivalents and current and long-term marketable securities.
3M Company and Subsidiaries
SUPPLEMENTAL FINANCIAL INFORMATION
NON-GAAP MEASURES – (CONTINUED)
(Unaudited)
12

-- 12 of 16 --

Description of special items:
In addition to reporting financial results in accordance with U.S. GAAP, the Company also provides various non-GAAP
measures that incorporate adjustments for the impacts of special items. Special items incorporated in the preparation of these
non-GAAP measures for the periods presented include the items described below:
Net costs for significant litigation:
• These relate to 3M's respirator mask/asbestos (which include Aearo and non-Aearo items), PFAS-related other
environmental, and Combat Arms Earplugs matters. Net costs include the impacts of changes in accrued liabilities
(including interest imputation on applicable settlement obligations), external legal fees, and insurance recoveries, along
with the associated tax impacts. These costs also include the impact on the determination of earnings per diluted share of
3M’s option to satisfy a portion of amounts under the Combat Arms Earplugs settlement in shares. 3M does not consider
the elements of the net costs associated with these matters to be normal, operating expenses related to the Company’s
ongoing operations, revenue generating activities, business strategy, industry, and regulatory environment. Net costs
related to respirator mask/asbestos are reflected as special items in the Safety and Industrial business segment while
those impacting operating income (loss) associated with PFAS-related other environmental and Combat Arms Earplugs
matters are reflected as corporate special items in Corporate and Unallocated. In addition, during the voluntary chapter
11 bankruptcy period (which began in July 2022 and ended in June 2023), costs associated with the Aearo portion of
respirator mask/asbestos matters were reflected in corporate special items in Corporate and Unallocated. Prior to the
bankruptcy, costs associated with Combat Arms Earplugs matters were reflected as part of special items in the Safety and
Industrial business segment. In the first quarter of 2024 and 2023, 3M made payments of approximately $371 million
and $73 million, respectively, related to net costs for significant litigation.
Divestiture costs:
• These include costs related to separating and divesting substantially an entire business segment of 3M following public
announcement of its intended divestiture, including net tax costs of entity structuring associated with the separation of
Solventum. These also include interest expense on debt issued by Solventum for the period outstanding prior to the April
1, 2024 completion of the separation of Solventum from 3M. In the first quarter of 2024 and 2023, 3M made payments
of approximately $134 million and $54 million, respectively, associated with divestiture costs.
Divestiture-related restructuring actions:
• In the third quarter of 2022, following the split-off of the Food Safety business, management approved and committed to
undertake certain restructuring actions addressing corporate functional costs across 3M in relation to the magnitude of
amounts previously allocated to the divested business. In the first quarter of 2024 and 2023, 3M made payments of
approximately $2 million and $3 million, respectively, associated with divestiture-related restructuring actions.
Manufactured PFAS products:
• These amounts relate to sales and estimates of income (loss) and associated activity regarding manufactured PFAS
products that 3M plans to exit by the end of 2025 included within the Transportation and Electronics business segment.
Estimated income does not contemplate impacts on non-operating items such as net interest income/expense and the non-
service cost components portion of defined benefit plan net periodic benefit costs. Relative to the impact of the activity
of manufactured PFAS products on cash provided by (used in) operating activities, amounts are based on estimates of
associated income, depreciation/amortization, certain changes in working capital and accruals, and timing of associated
payments.
3M Company and Subsidiaries
SUPPLEMENTAL FINANCIAL INFORMATION
NON-GAAP MEASURES – (CONTINUED)
(Unaudited)
13

-- 13 of 16 --

The spin-off of Solventum, the former 3M Health Care business, was completed on April 1, 2024. Beginning in the second
quarter of 2024, Solventum's historical net income will be reported within 3M's financial statements as discontinued operations.
However, 3M’s 2024 earnings outlook guidance reflects Solventum as discontinued operations for the full year, including the
first quarter of 2024. Therefore, 3M is supplying the accompanying preliminary estimated information that is illustrative as if
Solventum were reflected as a discontinued operation for certain historical periods. This financial information should be read
together with the financial information included in 3M’s Current Report on Form 8-K filed April 4, 2024, and with the audited
financial information (including the accompanying notes), Management Discussion and Analysis and other information
included in 3M’s Annual Report on Form 10-K for the year ended December 31, 2023. The financial information that follows
does not revise or otherwise amend or restate any previously filed financial information of 3M. This information is preliminary,
unaudited, and based on current estimates, and remains subject to change.
Reflecting Solventum income as discontinued operation 2024 forecast
2024 adjusted earnings per share (non-GAAP measure)5,10 $6.80 to $7.30
2024 adjusted other expense (income), net (non-GAAP measure)5,10 ~$75 to $100 million
2024 adjusted effective tax rate (non-GAAP measure)5,10 19% to 20%
103M provides these forward-looking non-GAAP measures, but cannot, without unreasonable effort, forecast certain items
to present or provide a reconciliation to corresponding forecasted GAAP measures. These include special items such as net costs for
significant litigation; projected divestiture gains; divestiture costs; divestiture-related restructuring; and net sales and estimates of income
and associated activity of exited manufactured PFAS products all of which are subject to limitations in predictability of timing, ultimate
outcome and numerous conditions outside of 3M’s control. 3M believes these limitations would result in a range of projected values so
broad as to not be meaningful to investors. For these reasons, 3M believes that the probable significance of such information is low.
Additionally, for similar reasons, 3M does not include the impact of potentially-divested or acquired businesses on expected operations
in forecasted outlook guidance it provides until close of a transaction. Information with respect to special items for certain historical
periods is included in the section entitled “Description of special items”.
3M Company and Subsidiaries
SUPPLEMENTAL FINANCIAL INFORMATION
NON-GAAP MEASURES - REFLECTING SOLVENTUM INCOME (LOSS) AS DISCONTINUED OPERATION
(Unaudited)
14

-- 14 of 16 --

(Dollars in billions, except per share
amounts) Net sales Sales
change
Operating
income (loss)
Operating
income (loss)
margin
Other
expense
(income),
net
Income (loss)
from
continuing
operations
before
income taxes
Provision
(benefit)
for income
taxes Effective tax
rate
Net income
(loss) from
continuing
operations
attributable
to 3M
Earnings
(loss) from
continuing
operations
per diluted
share
For the year ended December 31, 2022
As reported $ 34.2
Solventum discontinued
operations (8.1)
Revised - reflecting continuing
operations $ 26.2
Adjustments for special items:
Manufactured PFAS products (1.4)
Continuing operations adjusted
amounts (non-GAAP measures)5 $ 24.8
For the year ended December 31, 2023
As reported $ 32.7 (4.5) % $ (9.1) (27.9) % $ 0.6 $ (9.7) $ (2.7) 27.8 % $ (7.0) $ (12.63)
Solventum discontinued
operations (8.1) ~(1.5) to
(1.6) — ~(1.5) to
(1.6) ~(0.2) ~(1.3) to
(1.4) ~(2.46) to
(2.61)
Revised - reflecting continuing
operations $ 24.6 (5.9) % ~($10.6) to
($10.7) ~(43%) to
(44%) ~0.6 ~($11.2) to
($11.3) ~($2.9) ~25.4 to
25.5% ~($8.3) to
($8.4) ~($15.09)
to ($15.24)
Adjustments for special items:
Net costs for significant
litigation — 14.87 (0.4) 15.25 3.62 11.63 21.00
Manufactured PFAS products (1.3) 0.21 — 0.21 0.05 0.16 0.28
Gain on business divestitures — (0.04) — (0.04) (0.01) (0.03) (0.05)
Russia exit charges (benefits) — (0.02) — (0.02) 0.00 (0.02) (0.04)
Divestiture costs — 0.01 — 0.01 0.00 0.01 0.02
Total special items (1.3) 15.0 (0.4) 15.4 3.7 11.7 21.21
Continuing operations adjusted
amounts (non-GAAP measures)5 $ 23.3 (6.0) % ~$4.3 to
$4.4 ~18.5% to
18.9% ~$0.2 ~$4.1 to
$4.2 ~$0.8 ~19.1% to
19.3% ~$3.3 to
$3.4 ~$5.97 to
$6.12
Amounts may not foot or cross-foot due to rounding.
(Dollars in billions, except per share amounts) Net sales
Operating
income (loss)
Operating
income (loss)
margin
Other
expense
(income),
net
Income (loss)
from
continuing
operations
before
income taxes
Provision
(benefit)
for income
taxes Effective tax
rate
Net income
(loss) from
continuing
operations
attributable
to 3M
Earnings (loss)
from continuing
operations per
diluted share
For the quarter ended March 31, 2023
As reported $ 8.0 $ 1.2 15.4 % $ 0.1 $ 1.2 $ 0.2 17.7 % $ 1.0 $ 1.76
Solventum discontinued operations (2.0) ~(0.4) — ~(0.4) ~(0.1) ~(0.3) ~(0.55) to (0.58)
Revised - reflecting continuing operations $ 6.1 ~$0.9 ~14.1% to
14.5% $ 0.1 ~$0.8 ~$0.1 ~17.9% ~$0.7 ~$1.18 to $1.21
Adjustments for special items:
Net costs for significant litigation — 0.04 — 0.04 0.01 0.04 0.07
Manufactured PFAS products (0.3) (0.01) — (0.01) — (0.01) (0.01)
Divestiture costs — — — — — — —
Total special items (0.3) 0.04 — 0.04 0.00 0.03 0.06
Continuing operations adjusted amounts
(non-GAAP measures)5 $ 5.7 ~$0.9 ~15.6% to
16.0% ~$0.1 ~$0.8 to
$0.9 ~$0.1 to
0.2 ~17.7% ~$0.7 ~$1.24 to $1.27
For the quarter ended March 31, 2024
As reported $ 8.0 $ 1.5 18.8 % $ 0.3 $ 1.2 $ 0.3 24.7 % $ 0.9 $ 1.67
Solventum discontinued operations (2.0) ~0.3 to 0.4 — ~(0.3) ~(0.1) ~(0.2) ~(0.38) to (0.42)
Revised - reflecting continuing operations $ 6.0 ~$1.1 to
$1.2 ~18.9% to
19.3% ~$0.2 ~$0.9 ~$0.2 ~23.7% ~$0.7 ~$1.25 to $1.29
Adjustments for special items:
Net costs for significant litigation — 0.07 (0.20) 0.27 0.03 0.24 0.44
Manufactured PFAS products (0.3) — — — — — —
Divestiture costs — 0.01 — 0.01 — — —
Total special items (0.3) 0.07 (0.20) 0.28 0.03 0.25 0.44
Continuing operations adjusted amounts
(non-GAAP measures)5 $ 5.7 ~$1.2 ~21.1% to
21.5% — ~$1.2 ~$0.2 to
$0.3 ~20.9% ~$0.9 to
$1.0 ~$1.69 to $1.73
Amounts may not foot or cross-foot due to rounding.
3M Company and Subsidiaries
SUPPLEMENTAL FINANCIAL INFORMATION
NON-GAAP MEASURES - REFLECTING SOLVENTUM NET INCOME AS DISCONTINUED OPERATION -
(CONTINUED)
(Unaudited)
15

-- 15 of 16 --

Full-Year 2024 Forecast
Sales Change4 Organic sales Acquisitions Divestitures Translation Total sales change
Total Company10 flat to +2% — % 0.75 % (1) % (0.25%) to +1.75%
Remove manufactured PFAS products
impact10 — % — % — % — % — %
Adjusted total Company (non-GAAP
measures)5,10 flat to +2% — % 0.75 % (1) % (0.25%) to +1.75%
Year ended December 31, 2023
Sales Change4 Organic sales Acquisitions Divestitures Translation
Total sales
change
Total Company10 (4.2) % 0.3 % (1.3) % (0.7) % (5.9) %
Remove manufactured PFAS products impact10 (0.2) — — 0.1 (0.1)
Adjusted total Company (non-GAAP measures)5,10 (4.4) % 0.3 % (1.3) % (0.6) % (6.0) %
3M Company and Subsidiaries
SUPPLEMENTAL FINANCIAL INFORMATION
NON-GAAP MEASURES - REFLECTING SOLVENTUM NET INCOME AS DISCONTINUED OPERATION -
(CONTINUED)
(Unaudited)
16

-- 16 of 16 --